Thanks to WELTEC‘s customised design, biogas plants can also be operated in areas with high snowfall. (Image source: WELTEC)

Following the installation of several agricultural plants in recent years, WELTEC BIOPOWER has now reported an order for a 450 kW plant from the agricultural sector as well as a 250 kW biogas plant in Yamagata Prefecture, with an additional WELTEC BLUE WATER treatment, which is currently being implemented

Thanks to its many years of project experience in earthquake zones – in Japan and Greece – WELTEC BIOPOWER is able to adapt its technical solutions to seismically active areas in the shortest possible time using special structural engineering. Yamagata Prefecture has two digesters available to feed 80 tons of cattle manure per day. This is used to exclusively generate electricity and heat in the 250 kW plant. 

WELTEC's scope of supply also includes two storage tanks, a pump container, a separation unit and the combined heat and power plant (CHP). In addition to the biogas project, a WELTEC BLUE WATER plant with a processing capacity of 50,000 tons of digestate (manure and wastewater from milk production) per year is currently being constructed. The treatment technology works by separating the digestate from the biogas plant in a multi-stage process into solid and liquid fertiliser and dischargeable water. The resulting solid phase offers a wide range of marketing options, which includes its use as fertiliser in the field or as bedding in stables. This enables the operator to make additional savings on transport costs by reducing the volume of the source material. 

Output material distribution varies depending on the amount of dry matter present within the fermentation residue which comprises around 3% solid fertiliser, 29% nutrient concentrate and 68% water. Moreover, the sophisticated modular design of the industrial technology allows an ease in future expansion. 

Everyday, operators of the plant fill it with 18 tons of cattle manure, along with food waste from nearby areas. The modular digester system from WELTEC makes it possible to individually adapt the diameter and height to meet customers‘ volume requirements or local building regulations, such as height restrictions. The fermentation residue from the 450 kW plant is processed in sewage treatment plants near the sites before being used as fertiliser. A further plant is currently being planned in Nagano Prefecture. The height of the digester is also adapted as a special solution to 5.03 m and equipped with a capacity of 450 kW.  Another plant is currently being planned in Nagano Prefecture.

The WELTEC CONTROL software allows Japanese operators to get quick access to a number of important system parameters, with its intuitive user interface also simplifying feeding processes. 

The partnership advances the One Health platform of animal health solutions. (Image source: Elanco)

To leverage Medgene’s innovative vaccine platform technology, Elanco Animal Health Incorporated has entered into an agreement with the company to commercialise the highly pathogenic avian influenza (HPAI) vaccine for use in dairy cattle

Efforts by the poultry industry to reduce or irradiate HPAI spread have continued to be challenging as the current outbreak enters its fourth year. The cross-species and zoonotic transmission of the disease indicates the urgent need for intervention and calls for the development of a vaccine that can slow virus spread between birds and cattle.

“As egg prices soar and milk production wanes in infected dairies, the need for new solutions to curb disease spread is evident,” says Jeff Simmons, president and CEO of Elanco Animal Health, while expressing his pleasure to partner with Medgene. “This partnership further strengthens our diverse dairy portfolio and advances our One Health platform of animal health solutions, not only benefitting our dairy customers, but helping curb disease spread for our poultry customers, and working to improve egg prices for consumers.” 

This single-dose product comes in a 30 mL tube and should be administered after the calf has had colostrum. (Image source: Adobe Stock)

With their mission and commitment to care, BioZyme has introduced VitaFerm Sure Start Gel aimed at creating a positive impact on the health and wellbeing on animals, while also maximising efficiencies for producers

The new VitaFerm Sure Start Gel contains AO-Biotics Amaferm, a research-proven prebiotic that supports digestibility by stimulating beneficial microbes and offers several benefits to give newborns a sure start. Furthermore, it delivers IgY antibodies derived from Salmonella, E. coli, bovine rotavirus, bovine coronavirus, and Clostridium and MOS for broad support of the immune system. It also provides nutritional support to maximise calf vigor.  

This single-dose product comes in a 30 mL tube and should be administered after the calf has had colostrum. For best results, it is recommended to be given within the first 24 hours of birth and repeated daily as needed. The bright orange colour allows for distinct recognition of administration.

“Getting calves off to the best start possible is paramount for their long-term health and, ultimately, your profitability. While a year-round VitaFerm programme can improve colostrum quality, Sure Start Gel uses our new Broad-Shield technology to give an additional boost of immunity,” said BioZyme director of Beef Technical Sales, Chris Cassady. “VitaFerm Sure Start Gel is research-proven to enhance the efficacy of the antibodies the cow naturally passes to her calf, giving your calves every chance to develop their immune system and capitalise on healthy, efficient performance.”

This development enables the food industry to keep pace with growing protein demands. (Image source: Adobe Stock)

Foodtech innovator Ever After Foods partners with Bühler to help food producers around the world mass produce cultivated meat with the highest efficiency

While Bühler aims to address increasingly complex food system challenges, reduce environmental impact and improve food security through the development of equipment, Ever After Foods provides the technology to deliver commercial-scale production systems specifically designed to meet the needs of the cultivated meat sector. Cultivated meat producers can now reduce production costs by more than 90% while achieving unparalleled production efficiency.

Dedicated to leading a new era of scalability and sustainability for cultivated meat, Ever After Foods is working closely with select cultivated meat companies and top leaders in the food industry to accelerate the development and global deployment of its proprietary edible packed-bed (EPB) technology platform. Ever After Foods is actively creating scalable production solutions for clients, and its collaboration with Bühler will pave the way for dedicated and continued support of production solutions in the sector.

“The cultivated meat industry must move beyond relying on pharma-based technologies and adopt solutions specifically designed for food production,” said CEO of Ever After Foods, Eyal Rosenthal. “Our strategic collaboration with Bühler, a global leader in food equipment, is a critical step toward delivering scalable and efficient technologies that empower cultivated meat producers and food companies to bring their products to market. Together, we are driving the development of tailored solutions to sustainably scale cultivated meat production.”